Akt in ischemia and reperfusion

被引:262
作者
Mullonkal, Carolyn J.
Toledo-Pereyra, Luis H.
机构
[1] Michigan State Univ, Coll Human Med, Kalamazoo, MI USA
[2] Kalamazoo Ctr Med Studies, Dept Res, Kalamazoo, MI USA
关键词
Akt; signaling; ischemia; reperfusion;
D O I
10.1080/08941930701366471
中图分类号
R61 [外科手术学];
学科分类号
摘要
Injury due to ischemia and reperfusion (I/R) causes an inflammatory response due to oxidative damage, which triggers stress signaling processes that eventually result in cell apoptosis and death. There are a number of chemical mediators and pathways involved in the I/R response. Thus from a therapeutic point of view, it would be most efficient to focus on the most important active mediators of inflammation and apoptosis and manipulate these to improve cell function and survival. Over the last few years, the Akt pathway has become such a target due to its role as a signaling pathway where modulation of substrates prevents apoptosis. The involvement of Akt in the cell survival pathway is a complex process that requires an extensive machinery of intracellular events. The aim of this review is to organize these findings to better understand Akt's mechanism of protection and how it modulates specific substrates in the heart, liver, and brain affected by I/R. Akt functions as a survival kinase by phosphorylating a number of apoptosis-regulatory molecules such as BAD, forkhead transcription factors, caspase 9, and I kappa B kinase to influence NF-kappa B and GSK-3 beta. Akt's broad scope places it at the center of multiple critical steps, allowing it to play a protective role in various organs affected by I/R injury. From a practical and clinical application point of view, the upregulation of Akt could potentially be used alone or in combination with other therapeutic strategies to treat I/R injury and thus to improve cell and organ function. The means by which Akt manipulation should occur is not well defined, and it is possible that pharmacologically, such as in the case of selectin inhibitors in our experience or through well-orchestrated gene therapy, this important molecule can be better upregulated and therefore can offer effective protection. The short- and long-term effects with Akt upregulation have not been well studied so far. Early concerns about cancer or cardiac damage potential are inconclusive. Thus, more experiments are required in this particular area of research.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 49 条
[1]
Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival [J].
Akbar, M ;
Calderon, F ;
Wen, ZM ;
Kim, HY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :10858-10863
[2]
The molecular events underlying ischemia/reperfusion injury [J].
Anaya-Prado, R ;
Toledo-Pereyra, LH .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) :2518-2519
[3]
A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1 [J].
Bachmann, RA ;
Kim, JH ;
Wu, AL ;
Park, IH ;
Chen, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7357-7363
[4]
PKB binding proteins: Getting in on the akt [J].
Brazil, DP ;
Park, J ;
Hemmings, BA .
CELL, 2002, 111 (03) :293-303
[5]
Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation [J].
Casillas-Ramirez, Arani ;
Ben Mosbah, Ismail ;
Ramalho, Fernando ;
Rosello-Catafau, Joan ;
Peralta, Carmen .
LIFE SCIENCES, 2006, 79 (20) :1881-1894
[6]
Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma [J].
Chadha, Krishdeep S. ;
Khoury, Thaer ;
Yu, Jihnhee ;
Black, Jennifer D. ;
Gibbs, John F. ;
Kuvshinoff, Boris W. ;
Tan, Dongfeng ;
Brattain, Michael G. ;
Javle, Milind M. .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (07) :933-939
[7]
Future targets and cascades for neuroprotective strategies [J].
Chan, PH .
STROKE, 2004, 35 (11) :2748-2750
[8]
The Akt/PKB pathway: molecular target for cancer drug discovery [J].
Cheng, JQ ;
Lindsley, CW ;
Cheng, GZ ;
Yang, H ;
Nicosia, SV .
ONCOGENE, 2005, 24 (50) :7482-7492
[9]
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling [J].
Cittadini, A ;
Monti, MG ;
Iaccarino, G ;
Di Rella, F ;
Tsichlis, PN ;
Di Gianni, A ;
Strömer, H ;
Sorriento, D ;
Peschle, C ;
Trimarco, B ;
Saccà, L ;
Condorelli, G .
GENE THERAPY, 2006, 13 (01) :8-19
[10]
Transcriptional effects of chronic Akt activation in the heart [J].
Cook, SA ;
Matsui, T ;
Li, L ;
Rosenzweig, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22528-22533